Cytokinetics, Inc. (CYTK)

[H2R]

Orphan Designation for CYTK Treatment of spinal muscular atrophy

https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=516215

 
 Generic Name:	             fast skeletal muscle troponin activator 
 Trade Name:	             N/A 
 Date Designated:	     05/11/2017 
 Orphan Designation:	     Treatment of spinal muscular atrophy 
 Orphan Designation Status:   Designated 
 FDA Orphan Approval Status:  Not FDA Approved for Orphan Indication 
 Marketing Approval Date:    N/A 
 Approved Labeled Indication:	  
 Exclusivity End Date:	    N/A 
 Sponsor:	            Cytokinetics, Inc. 
                             280 East Grand Avenue 
                             South San Francisco, California 94080 
                             USA